Peptides serve as critical biological signaling molecules and therapeutic agents that bridge the gap between small molecules and large proteins, offering unique advantages in precision medicine and disease treatment.

Peptides function as essential signaling entities across all domains of life, mediating protein-protein interactions that are indispensable for biological processes.  They carry fundamental molecular information and act as fragments of proteins that execute diverse biological functions throughout the body. 

Diagnostic Applications

• Natriuretic peptides (BNP and NT-proBNP) demonstrate superior diagnostic accuracy for heart failure compared to clinical judgment alone, with ROC curves of 0.94 versus 0.90 (p=0.006). 
• BNP <100 pg/mL effectively excludes acute heart failure with 90% sensitivity and 94% negative predictive value, while BNP >400 pg/mL strongly indicates heart failure with a positive likelihood ratio exceeding 10. 
• NT-proBNP <300 pg/mL in non-acute settings has a 98% negative predictive value for heart failure, making cardiac failure highly unlikely. 
• These peptide biomarkers provide convenient, noninvasive approaches to detect disease severity and guide management decisions in heart failure. 

Prognostic Significance

• For each 100 pg/mL increase in BNP, the relative risk of death increases by approximately 35% over 1.5-3 years (95% CI: 22-49%). 
• Elevated natriuretic peptide levels predict increased risk of death, heart failure hospitalization, atrial fibrillation, and stroke. 
• Elevated preoperative BNP predicts postoperative cardiovascular events in non-cardiac surgery, helping identify high-risk surgical patients. 

Therapeutic Advantages

Peptides offer an optimal balance of specificity, safety, and molecular size, providing greater precision in targeting specific receptors with fewer off-target effects and reduced toxicity compared to small-molecule drugs. 

Key Therapeutic Benefits

• Peptides demonstrate higher efficiency in tissue penetration and cell internalization compared to antibodies, despite having lower affinity and shorter half-life. 
• They exhibit enhanced tissue penetration with simpler, cheaper manufacturing processes and lower immunogenicity than larger biologics. 
• Peptides are highly selective and efficacious while remaining relatively safe and well-tolerated. 
• The global peptide therapeutics market is projected to exceed USD 50 billion by 2024, with approximately 100 peptides having attained clinical approval in major markets. 

Clinical Applications

• Peptides serve as tumor-homing ligands for delivering carriers (nanoparticles, extracellular vesicles, cells) and cargoes (cytotoxic peptides, radioisotopes) to tumors. 
• They function as peptide-drug conjugates when conjugated with chemotherapeutic drugs via linkers. 
• Peptides selectively bind to cell surface receptors including immune checkpoints, receptor kinases, and hormone receptors, blocking their biological activity or serving as hormone analogs. 
• They treat metabolic disorders, cancer, and serve as antimicrobial and anti-inflammatory agents.